SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants Class 1 Review To Encysive Pharmaceuticals' Complete Response To Thelin(TM) (Sitaxsentan Sodium) New Drug Application; PDUFA Is July 24, 2006